Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

Core Insights - Obagi Medical has launched a new product, Retinol + PHA Refining Night Cream, which combines Entrapped Retinol and Polyhydroxy Acid (PHA) for enhanced skin renewal and improved complexion [3][4] - The product is designed to be effective yet gentle, making it suitable for individuals with sensitive skin or those new to retinoids [4][5] - Clinical studies show significant improvements in skin texture and tone, with a 2.3x increase in participants feeling comfortable in their skin after eight weeks of use [6][7] Product Details - The Retinol + PHA Refining Night Cream utilizes a slow-release delivery system for retinol, minimizing irritation while maximizing efficacy [4][5] - The formulation includes eight additional dermatologically recognized ingredients to support hydration and skin resilience [6][11] - The product is priced at $135 and will be available for purchase on Obagi's website starting May 5, 2025 [6] Clinical Efficacy - A four-week clinical study demonstrated a 29% increase in skin smoothness and a 10% improvement in skin tone evenness among participants [11] - 90% of users reported visibly smoother skin texture, and 90% observed a reduction in the appearance of blemishes [11] Company Background - Obagi Medical is recognized as the fastest-growing professional skincare brand in the U.S. in 2024, with a legacy of over 35 years in advanced skincare [8][9] - The brand is known for its physician-recommended skincare solutions, particularly for addressing hyperpigmentation, fine lines, and wrinkles [8][9]